Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children : Therapeutic Drug Monitoring

Secondary Logo

Journal Logo

Original Article

Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children

Siemens, Angela MSc*,†; Brooks, Beth MSc; Rassekh, S. Rod MD†,§; Meijer, Annelot J.M. PhD; van den Heuvel-Eibrink, Mary M. MD, PhD¶,║; Xu, Wei PhD**; Loucks, Catrina M. PhD†,††,‡‡; Ross, Colin J.D. PhD*,†,§§; Carleton, Bruce C. PharmD*,†,††,¶¶;  on behalf of the Canadian Pharmacogenomics Network for Drug Safety Consortium

Author Information
Therapeutic Drug Monitoring 45(3):p 345-353, June 2023. | DOI: 10.1097/FTD.0000000000001085

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid